Intraday BUY SELL Signals
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
ECAT vs XRLX
ECAT vs XRLX Comparison
Open Charts ECAT vs XRLX
ECAT vs XRLX Comparison Chart in %
Loading...
loading
loading
View a ticker or compare two or three
VS
VS
ECAT vs. XRLX commentary
Jun 24, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECAT is a Buy and XRLX is a Buy.
SUMMARIES
FUNDAMENTALS
Fundamentals
ECAT has more net assets: 1.57B vs. XRLX (51M). ECAT has a higher annual dividend yield than XRLX: ECAT (12.057) vs XRLX (7.554). ECAT was incepted earlier than XRLX: ECAT (5 years) vs XRLX (24 years). XRLX (1.20) has a lower expense ratio than ECAT (1.30). ECAT has a higher turnover XRLX (84.00) vs XRLX (84.00).
| ECAT | XRLX | ECAT / XRLX | |
| Gain YTD | 12.057 | 7.554 | 160% |
| Net Assets | 1.57B | 51M | 3,082% |
| Total Expense Ratio | 1.30 | 1.20 | 108% |
| Turnover | 226.00 | 84.00 | 269% |
| Yield | 1.37 | 2.57 | 53% |
| Fund Existence | 5 years | 24 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| ECAT | XRLX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 72% | 2 days ago 58% |
| Stochastic ODDS (%) | 2 days ago 81% | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 88% |
| MACD ODDS (%) | 2 days ago 70% | 2 days ago 65% |
| TrendWeek ODDS (%) | 2 days ago 85% | 2 days ago 84% |
| TrendMonth ODDS (%) | 2 days ago 86% | 2 days ago 84% |
| Advances ODDS (%) | 9 days ago 83% | 9 days ago 82% |
| Declines ODDS (%) | 16 days ago 79% | 7 days ago 58% |
| BollingerBands ODDS (%) | 2 days ago 71% | 2 days ago 55% |
| Aroon ODDS (%) | 2 days ago 89% | 2 days ago 83% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNAX | 80.74 | 1.47 | +1.85% |
| Janus Henderson Global Life Sciences A | |||
| ACIOX | 13.88 | N/A | N/A |
| American Century International Opps I | |||
| VECRX | 23.68 | N/A | N/A |
| Virtus KAR Equity Income R6 | |||
| TAAHX | 37.53 | N/A | N/A |
| Transamerica Multi-Managed Balanced R | |||
| GFAFX | 86.54 | -0.46 | -0.53% |
| American Funds Growth Fund of Amer F1 | |||
ECAT and
Correlation & Price change
A.I.dvisor indicates that over the last year, ECAT has been loosely correlated with BSX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ECAT jumps, then BSX could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To ECAT | 1D Price Change % | ||
|---|---|---|---|---|
| ECAT | 100% | N/A | ||
| BSX - ECAT | 64% Loosely correlated | -2.12% | ||
| CRM - ECAT | 62% Loosely correlated | -1.09% | ||
| AMT - ECAT | 56% Loosely correlated | +0.22% | ||
| NEE - ECAT | 55% Loosely correlated | -0.77% | ||
| MSFT - ECAT | 12% Poorly correlated | -3.18% | ||
More | ||||